v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 65,300 $ 71,367
Marketable securities 131,147 195,317
Accounts receivable 1,761 1,504
Related party collaboration receivable 151 676
Prepaid expenses and other current assets 4,328 7,945
Total current assets 202,687 276,809
Property and equipment, net 13,136 14,314
Restricted cash 2,736 2,874
Marketable securities 5,244 65,704
Operating lease right-of-use assets 28,478 33,349
Total assets 252,281 393,050
Current liabilities:    
Accounts payable 5,013 3,996
Accrued expenses 12,098 14,171
Operating lease liabilities 7,840 7,227
Deferred revenue 1,590 24,394
Total current liabilities 26,541 49,788
Operating lease liabilities, net of current portion 28,659 36,499
Deferred revenue, net of current portion   6,003
Other non-current liabilities 1,000 1,000
Total liabilities 56,200 93,290
Commitments, contingencies, and other liabilities (see note 8)
Stockholders' equity:    
Preferred stock, $0.001 par value: 5,000,000 shares authorized; no shares issued and outstanding at December 31, 2025 and 2024
Common stock, $0.001 par value: 120,000,000 shares authorized; 59,047,860 and 54,731,316 shares issued and outstanding at December 31, 2025 and 2024, respectively 59 55
Additional paid-in capital 641,895 626,296
Accumulated other comprehensive income (loss) 32 (407)
Accumulated deficit (445,905) (326,184)
Total stockholders' equity 196,081 299,760
Total liabilities and stockholders' equity $ 252,281 $ 393,050